Aarhus University logo
ODIN has reserved DKK 23.9 million for six new research projects that will pave the way for new drugs to treat a wide range of medical conditions –…
The IMPAD project focuses on Parkinson’s disease (PD), a brain disease with so far no cure. PD therapeutic development is limited by the lack of novel…
Chronic kidney disease (CKD) is a growing cause of global mortality. Yet, pre-clinical research and drug development are hampered by the lack of good…
The BALDER team will develop novel statistical modelling approaches that use correlated trait information to fully utilize genomic data for…
Cell Culture in a 2D format remains an important in vitro system for screening and early validation of drug candidates, however cells in in vitro…
Mental disorders are the leading causes of disability worldwide. In the BioPsych project, de-regulated noncoding RNAs will be identified in postmortem…
The ultimate aim of the P2P CPP project is to develop a safe and efficient means of getting drugs into cells. The strategy is inspired by nature,…
The BALDER team will develop statistical modelling approaches to identify novel drug targets for Type 2 Diabetes. The AU team will collaborate in an…
The BioPsych project team will use the Danish Brain Collection to identify biomarkers in the human psychiatric brain. The AU project team collaborates…
FRIGG is an open collaboration between AU researchers and industry representatives from AstraZeneca, Nordic Bioscience, and Novo Nordisk. Their aim is…
Page 6 of 10
